MilliporeSigma Webinars

31. Unleashing The Power Of Perfusion In Intensified Processes 5/28/2024

    Explore the advantages of implementing a perfusion-specific CLD process to produce more productive clones as well as an integrated solution for intensified processing.

32. Key Quality Attributes For mRNA Drug Substance Performance 5/23/2024

    Explore the evolution of the mRNA-based therapeutics pipeline, and gain insights into the key quality attributes and associated analytics that influence mRNA performance, including best practices.

33. How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing 5/23/2024

    Gain valuable insights into key considerations when selecting lipid excipients for LNP formulations and the process development steps necessary to advance them to GMP manufacturing and clinical trials.

34. An Early Formulation Screening Service 5/23/2024

    Gain insights into overcoming the challenges in lipid nanoparticle (LNP) formulation, explore critical aspects of the process and analytical development of LNPs, and much more.

35. PAT Implementation For ADC And Bioconjugation Processes 3/1/2024

    Explore expert insights into the implementation of Process Analytical Technology (PAT) for ADC and bioconjugation processes and the pros and cons of in(on)line testing for the conjugation process.

36. Advancements In Process And Payload Development 2/29/2024

    Continuous advancements in the process and payload development of ADCs and next-generation bioconjugates have the potential to progress targeted therapeutics and improve patient treatment options.

37. Enable Upstream Intensified Bioprocessing Using Modular Bioreactors 1/19/2024

    Discover a new technology that has been developed with flexibility, scalability across sizes, and an expanded design space to meet the increased performance needs of intensified bioprocesses.

38. Risk Assessment For Carcinogenic Substances In The Lab 11/20/2023

    Learn how to apply the STOP hierarchy of protective measures to carcinogens and easily document the four key steps of risk assessment.

39. The Closed Processing Advantage: Optimizing Biopharma Facilities 11/16/2023

    Explore the evolving landscape of biopharma facility design and operations, including key market trends, closed processing benefits, and industry efforts to harmonize guidance and best practices.

40. Accelerate Development And De-Risk Gene Therapy Manufacturing 10/20/2023

    Join viral vector process and analytical development experts as they showcase strategies for developing robust processes and analytics for efficient and de-risked manufacturing.